ZymoGenetics | Evaluate

February 25, 2011

Vantage Point – Need for safer hep C interferons spurring more research

September 08, 2010

Bristol-Myers Squibb deals for new gentler and kinder interferon

June 12, 2009

Therapeutic focus – Lupus needs shots on goal to hit the mark

June 05, 2009

Anadys' bubble burst by lack of partner

February 06, 2009

Failure to launch for last year's big hopes

January 19, 2009

Most valuable product deals in 2008

January 14, 2009

Unpartnered hep C assets to attract attention

January 13, 2009

Bristol-Myers, Zymo deal shows interest in hep C remains high

December 04, 2008

Delay to Roche's Actemra robs 2008 of its biggest approval

November 05, 2008

ZymoGenetics' Recothrom set to be one of the most disappointing new product launches of 2008

September 04, 2008

ZymoGenetics gives up R&D ghost to save cash

Load More